＜東証＞エーザイが10%高　認知症薬のFDA承認期待で

＜東証＞エーザイが10%高　認知症薬のFDA承認期待で
https://www.nikkei.com/article/DGXLASFL06HOI_W0A101C2000000

last-modified: 2020-11-06 12:56:37